LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want access to our free earnings report on UnitedHealth Group Inc. (NYSE: UNH) ("UNH"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=UNH. The Company reported its financial results on July 17, 2018, for the second quarter of the fiscal year 2018, ended June 30, 2018. For Q2 FY18, the Company?s revenues were in-line with analysts? consensus estimates, while its earnings surpassed forecasts. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, UnitedHealth Group most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=UNH

Earnings Highlights and Summary

For Q2 FY18, UNH?s total revenues reached $56.09 billion, reflecting an increase of 12.05% from $50.05 billion in Q2 FY17. The Company?s reported total revenue numbers were in-line with analysts? consensus estimates.

During the quarter under review, UNH?s premium revenues increased 12.31% to $44.46 billion on a y-o-y basis; its product revenues advanced 9.18% to $7 billion on a y-o-y basis; and its services revenues jumped 12.43% to $4.27 billion on a y-o-y basis.

UNH incurred total operating costs of $51.88 billion in Q2 FY18, up 12% from $46.32 billion in Q2 FY17. For the reported quarter, the Company?s medical costs advanced 11.91% to $36.43 billion on a y-o-y basis; while its operating costs jumped 14.44% to $8.39 billion on a y-o-y basis. The Company?s cost of products sold also increased 9.88% to $6.47 billion on a y-o-y basis in Q2 FY18. UNH?s earnings from operations were $4.20 billion in the quarter under review, up 12.68% from $3.73 billion in the year ago same quarter.

UNH?s net earnings attributable to common shareholders were $2.92 billion in the quarter ended June 30, 2018, up 27.93% from $2.28 billion in the comparable period of last year. The Company?s diluted earnings per share (EPS) advanced 28.45% to $2.98 in Q2 FY18 from $2.32 in Q2 FY17. UNH?s adjusted diluted EPS, excluding these non-recurring items, were $3.14 in Q2 FY18, up 27.64% from $2.46 in Q2 FY17; and exceeded analysts? consensus estimates by $0.10 per share.

Segment Details

During Q2 FY18, UNH?s UnitedHealthcare segment?s revenues were $45.85 billion; reflecting an increase of 12.40% on a y-o-y basis, which was driven by an increasing number of people served, a higher revenue membership mix, pricing increases to cover expected medical cost trends, and the resumption of the health insurance tax for 2018. The segment had operating earnings of $2.36 billion in the reported quarter, 6.60% higher than $2.21 billion in the previous year?s corresponding quarter.

UNH?s Optum segment reported revenues of $24.73 billion in Q2 FY18, 9.06% higher than in the previous year?s same quarter. The segment had earnings from operations of $1.85 billion in the quarter under review, representing an increase of 21.51% from $1.52 billion in Q2 FY17. This growth was led by a double-digit percentage earnings growth in each of its business segments.

Cash Matters

UNH had cash and short-term investments of $21.86 billion as on June 30, 2018, 41.12% higher than $15.49 billion as on December 31, 2017. UNH?s long-term debt, less current maturities, stood at $32.10 billion as on June 30, 2018, 11.31% higher than $28.84 billion as on December 31, 2017.

For the six months ended June 30, 2018, UNH?s cash flow from operating activities was $12.38 billion, reflecting an increase of 43.46% from $8.63 billion in the comparable period of last year. On a non-GAAP basis, UNH had adjusted cash flow from operations of $7.21 billion in H1 FY18, 72.78% higher than $4.17 billion in H1 FY17.

During H1 FY18, UNH paid dividends of $1.59 billion, 20.03% higher than $1.32 billion in H1 FY17. The Company spent $3.15 billion on common stock repurchases in the reported quarter compared to $1.05 billion in the prior year?s corresponding quarter.

UNH spent $960 million on purchases of property, equipment, and capitalized software in H1 FY18, 3.78% higher than $925 million in H1 FY17.

Outlook

UNH increased its guidance for FY18 on the basis of the results for H1 FY18 and the encouraging business outlook for the rest of the year. The Company now expects diluted EPS to be in the range of $11.80 to $12.05, and adjusted diluted EPS to be in the band of $12.50 to $12.75 for FY18.

Stock Performance Snapshot

July 18, 2018 - At Wednesday?s closing bell, UnitedHealth Group?s stock advanced 2.05%, ending the trading session at $255.42.

Volume traded for the day: 3.30 million shares, which was above the 3-month average volume of 2.65 million shares.

Stock performance in the last month ? up 0.22%; previous three-month period ? up 8.05%; past twelve-month period ? up 36.70%; and year-to-date ? up 15.86%

After yesterday?s close, UnitedHealth Group?s market cap was at $241.55 billion.

Price to Earnings (P/E) ratio was at 25.18.

The stock has a dividend yield of 1.41%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.2% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors